HomeComparePRXXF vs JNJ

PRXXF vs JNJ: Dividend Comparison 2026

PRXXF yields 4.05% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PRXXF wins by $1935.49M in total portfolio value
10 years
PRXXF
PRXXF
● Live price
4.05%
Share price
$12.60
Annual div
$0.51
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1935.52M
Annual income
$1,847,900,539.35
Full PRXXF calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — PRXXF vs JNJ

📍 PRXXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPRXXFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PRXXF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PRXXF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PRXXF
Annual income on $10K today (after 15% tax)
$344.38/yr
After 10yr DRIP, annual income (after tax)
$1,570,715,458.45/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, PRXXF beats the other by $1,570,711,472.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PRXXF + JNJ for your $10,000?

PRXXF: 50%JNJ: 50%
100% JNJ50/50100% PRXXF
Portfolio after 10yr
$967.77M
Annual income
$923,952,614.37/yr
Blended yield
95.47%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

PRXXF
Analyst Ratings
1
Hold
1
Sell
Consensus: Hold
Altman Z
13.9
Piotroski
6/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PRXXF buys
0
JNJ buys
0
No recent congressional trades found for PRXXF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPRXXFJNJ
Forward yield4.05%2.13%
Annual dividend / share$0.51$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$1935.52M$30.3K
Annual income after 10y$1,847,900,539.35$4,689.40
Total dividends collected$1929.26M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: PRXXF vs JNJ ($10,000, DRIP)

YearPRXXF PortfolioPRXXF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,510$810.32$10,592$272.30+$918.00PRXXF
2$14,059$1,743.37$11,289$357.73+$2.8KPRXXF
3$19,024$3,980.29$12,123$472.89+$6.9KPRXXF
4$30,422$10,066.82$13,141$629.86+$17.3KPRXXF
5$62,643$30,090.73$14,408$846.81+$48.2KPRXXF
6$182,840$115,812.74$16,021$1,151.60+$166.8KPRXXF
7$827,476$631,836.32$18,122$1,588.22+$809.4KPRXXF
8$6,230,229$5,344,829.74$20,930$2,228.20+$6.21MPRXXF
9$81,885,581$75,219,236.20$24,792$3,191.91+$81.86MPRXXF
10$1,935,518,111$1,847,900,539.35$30,274$4,689.40+$1935.49MPRXXF

PRXXF vs JNJ: Complete Analysis 2026

PRXXFStock

Paradox Interactive AB (publ) develops and publishes games and brands for PC, mobile, and console platforms primarily in North and Latin America, Europe, the Middle East, Africa, and the Asia Pacific region. The company's game portfolio comprises various franchises and brands, including Stellaris, Europa Universalis, Hearts of Iron, Crusader Kings, Cities: Skylines, Surviving Mars, Prison Architect, Magicka, Age of Wonders, Victoria, and the World of Darkness. Paradox Interactive AB (publ) was founded in 1998 and is headquartered in Stockholm, Sweden.

Full PRXXF Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this PRXXF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PRXXF vs SCHDPRXXF vs JEPIPRXXF vs OPRXXF vs KOPRXXF vs MAINPRXXF vs ABBVPRXXF vs MRKPRXXF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.